Maynard Um
-
-
-
-
-
-
-
Illumina (ILMN) PT Raised to $200 at Piper Sandler
-
-
-
-
-
-
-
Illumina launches whole-genome sequencing kit for cancer research
-
-
-
-
-
-
-
Barclays: Life science insiders sold $187M in stock during first quarter
-
-
-
-
-
-
-
Wolfe: 'Roche Consumables Priced at $150/genome, Though There Are Some Nuances/Limits?; Launch Mid-2026'
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)
-
-
-
-
-
-
-
Illumina launches cloud-based multiomic research software platform
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Illumina (ILMN)
-
433,566 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

